SEC Tracker
Get the app

Propanc Biopharma PPCB

Propanc Biopharma delisted from Nasdaq

Nasdaq bid price notice, Item 3.01 Listing standards notice

Form
8-K
Filed
Importance
Major
  1. Received notice of delisting due to bid price below $1.00
  2. Delisting scheduled for November 2, 2026
  3. Company plans to appeal decision by October 30, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Propanc Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cannapharmarx CPMD public float $3M, Jun 30, 2025
  2. MetaVia MTVA public float $3M, Jun 30, 2025
  3. Oragenics OGEN public float $3M, Jun 30, 2025
  4. Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
  5. PTC Therapeutics PTCT public float $3M, Jun 30, 2025